Source: International Congress 2016 – Extracellular vesicles in lung disease pathogenesis



Rating:

Share or cite this content

Citations should be made in the following way:
Jae-Woo Lee (San Francisco, United States of America). Human mesenchymal stem cell microvesicles for the treatment of Escherichia coli endotoxin-induced acute lung injury. International Congress 2016 – Extracellular vesicles in lung disease pathogenesis

Member's Comments

No comment yet.

Related content which might interest you: Human mesenchymal stem cell exosomes attenuate inflammation of lung epithelial cells through miR-223 in acute lung injury Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Characterization of human mesenchymal stem cells phenotype and secretome in a in vitro model of acute lung injury inflammation Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011 Mesenchymal stem cell based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysacharride in mice Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury Year: 2008 Adrenaline stimulated mesenchymal stem cells modulate inflammation in lipopolysaccharide induced lung injury Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair Year: 2012 Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury Source: Eur Respir J, 59 (1) 2004216; 10.1183/13993003.04216-2020 Year: 2022 Extracellular vesicles derived from mesenchymal stem cells prevent pulmonary vascular dysfunction induced by lipopolysaccharide (LPS). Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 Secreted mediators from induced pluripotent stem cells (iPSc) attenuate fibrosis in bleomycin injured rat lung Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair Year: 2012 Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 Successful transplantation of rat mesenchymal stem cells, for the therapy of bleomycin induced lung injury Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis Year: 2010 Mesenchymal stem cells and recombinant erythropoietin treatment in an experimental sepsis model Source: Annual Congress 2012 - The many roads to lung injury Year: 2012 The new-defined mesenchymal stromal/stem cell marker has a protective role in the development of acute lung injury. Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling Year: 2019 Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells Source: Eur Respir J 2012; 39: 446-457 Year: 2012 Mesenchymal stem cells prevent early inflammation in a rat model of ventilator induced lung injury Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment Year: 2011 Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury Source: Eur Respir J 2009; 34: 740 Year: 2009 Modified mesenchymal stem cells attenuate bleomycin induced lung injury in the rat Source: Annual Congress 2010 - Stem cells and growth factors in lung injury Year: 2010 Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 205-221 Year: 2021 Pulmonary transplantation of human induced pluripotent stem cell-derived macrophages Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside Year: 2019 Mesenchymal stem cell-conditioned medium induces neutrophils apoptosis via inhibition of NF-kB pathway and increases endogenous pulmonary stem cells in endotoxin-induced acute lung injury Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015 Using induced pluripotent stem cells to model the human lung alveolar epithelium Source: International Congress 2018 – Pathophysiology of the human lung alveolus Year: 2018